JAG1 overexpression contributes to Notch1 signaling and the migration of HTLV-1-transformed ATL cells

about

JAG1 overexpression contributes to Notch1 signaling and the migration of HTLV-1-transformed ATL cells

Item

http://www.wikidata.org/entity/Q58718804

description

scientific article published on 19 September 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у вересні 2018

@uk

name

JAG1 overexpression contribute ...... f HTLV-1-transformed ATL cells

@en

JAG1 overexpression contribute ...... f HTLV-1-transformed ATL cells

@nl

type

Item

label

JAG1 overexpression contribute ...... f HTLV-1-transformed ATL cells

@en

JAG1 overexpression contribute ...... f HTLV-1-transformed ATL cells

@nl

prefLabel

JAG1 overexpression contribute ...... f HTLV-1-transformed ATL cells

@en

JAG1 overexpression contribute ...... f HTLV-1-transformed ATL cells

@nl

P1476

JAG1 overexpression contribute ...... f HTLV-1-transformed ATL cells

@en

P2093

Christophe Nicot

http://www.w3.org/2001/XMLSchema#string

Hassiba Chaib-Mezrag

http://www.w3.org/2001/XMLSchema#string

Marcia Bellon

http://www.w3.org/2001/XMLSchema#string

Ramona Moles

http://www.w3.org/2001/XMLSchema#string

P2860

The notch ligand JAGGED1 as a target for anti-tumor therapy

AIP4/Itch regulates Notch receptor degradation in the absence of ligand

Jagged-1 mediated activation of notch signaling induces complete maturation of human keratinocytes through NF-kappaB and PPARgamma

HTLV-1 Infection and Adult T-Cell Leukemia/Lymphoma-A Tale of Two Proteins: Tax and HBZ

Clinical significance of microRNAs in chronic and acute human leukemia

The Notch ligands, Jagged and Delta, are sequentially processed by alpha-secretase and presenilin/gamma-secretase and release signaling fragments

High-level coexpression of JAG1 and NOTCH1 is observed in human breast cancer and is associated with poor overall survival

Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia

FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation

Notch inhibition as a promising new approach to cancer therapy.

P2888

s13045-018-0665-6

P304

119

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13045-018-0665-6

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Joanna Pancewicz

P577

2018-09-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1107111989

http://www.w3.org/2001/XMLSchema#string

P698

30231940

http://www.w3.org/2001/XMLSchema#string

P921

P932

6146899

http://www.w3.org/2001/XMLSchema#string